Log in to save to my catalogue

Tamsulosin use in benign prostatic hyperplasia and risks of Parkinson's disease, Alzheimer's disease...

Tamsulosin use in benign prostatic hyperplasia and risks of Parkinson's disease, Alzheimer's disease...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_3096038078

Tamsulosin use in benign prostatic hyperplasia and risks of Parkinson's disease, Alzheimer's disease and mortality: An observational cohort study of elderly Medicare enrollees

About this item

Full title

Tamsulosin use in benign prostatic hyperplasia and risks of Parkinson's disease, Alzheimer's disease and mortality: An observational cohort study of elderly Medicare enrollees

Publisher

United States: Public Library of Science

Journal title

PloS one, 2024-08, Vol.19 (8), p.e0309222

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

Subjects

Subjects and topics

More information

Scope and Contents

Contents

To study the effects of benign prostatic hyperplasia treatments, namely: alpha-adrenergic receptor blockers, 5-alpha-reductase inhibitors and phosphodiesterase-5 inhibitors on the risk of Parkinson's disease, Alzheimer's disease and mortality.
All male Medicare enrollees aged 65 or above who were diagnosed with benign prostatic hyperplasia and r...

Alternative Titles

Full title

Tamsulosin use in benign prostatic hyperplasia and risks of Parkinson's disease, Alzheimer's disease and mortality: An observational cohort study of elderly Medicare enrollees

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_3096038078

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_3096038078

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0309222

How to access this item